BioScrip, Inc. to Present at Noble Financials Fifth Annual Equity Conference

ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the upcoming Nobel Financial Fifth Annual Equity Conference to be held June 8-9, 2009 at Hard Rock Hotel & Casino located in Hollywood, Florida.

BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will present Monday, June 8th at 1:55 p.m. ET (Eastern Time).

Investors may access the live audio web cast of BioScrip's presentation at the following link: http://hosted.mediasite.com/mediasite/Viewer/?peid=7f808e0b2ddc47efae648fea90237d0a. A web cast replay of the presentation may also be accessed via BioScrip’s website at www.bioscrip.com under the Investors Section until Monday, June 22nd.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex health care conditions.

Forward Looking Statements-Safe Harbor

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

BioScrip, Inc.
Stanley G. Rosenbaum, 952-979-3768
Executive Vice President and Chief Financial Officer
srosenbaum@bioscrip.com
or
In-Site Communications
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com